Evidence map›Paper›PMID 40440576›Full record

ArticlePLoS neglected tropical diseases2025

Cognitive impairment in Chagas disease patients in Brazil, 2007-2021: A cross-sectional study.

Carla J Serrano, Maria E Lisbôa-Marques, Thiago Cerqueira-Silva, Leila S B Santos, Murilo A Oliveira, Iuri Ferreira Felix, Paulo R S P de Sousa, Leonardo G M Cardoso, Pedro J R Muiños, Renata M Maia and 10 more

Abstract readMulticenter Study
In one paragraph

Article in PLoS neglected tropical diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Carla J SerranoStroke and Cardiomyopathy Clinics, Hospital Universitário Professor Edgard Santos, Universidade Federal da Bahia, Salvador, Brazil.ORCID 0000-0001-5968-7036
Maria E Lisbôa-MarquesStroke and Cardiomyopathy Clinics, Hospital Universitário Professor Edgard Santos, Universidade Federal da Bahia, Salvador, Brazil.
Thiago Cerqueira-SilvaStroke and Cardiomyopathy Clinics, Hospital Universitário Professor Edgard Santos, Universidade Federal da Bahia, Salvador, Brazil.
Leila S B SantosStroke and Cardiomyopathy Clinics, Hospital Universitário Professor Edgard Santos, Universidade Federal da Bahia, Salvador, Brazil.
Murilo A OliveiraStroke and Cardiomyopathy Clinics, Hospital Universitário Professor Edgard Santos, Universidade Federal da Bahia, Salvador, Brazil.
Iuri Ferreira FelixStroke and Cardiomyopathy Clinics, Hospital Universitário Professor Edgard Santos, Universidade Federal da Bahia, Salvador, Brazil.
Paulo R S P de SousaStroke and Cardiomyopathy Clinics, Hospital Universitário Professor Edgard Santos, Universidade Federal da Bahia, Salvador, Brazil.
Leonardo G M CardosoStroke and Cardiomyopathy Clinics, Hospital Universitário Professor Edgard Santos, Universidade Federal da Bahia, Salvador, Brazil.
Pedro J R MuiñosStroke and Cardiomyopathy Clinics, Hospital Universitário Professor Edgard Santos, Universidade Federal da Bahia, Salvador, Brazil.
Renata M MaiaStroke and Cardiomyopathy Clinics, Hospital Universitário Professor Edgard Santos, Universidade Federal da Bahia, Salvador, Brazil.
Marília B CattoStroke and Cardiomyopathy Clinics, Hospital Universitário Professor Edgard Santos, Universidade Federal da Bahia, Salvador, Brazil.
Eric Aguiar WittlichStroke and Cardiomyopathy Clinics, Hospital Universitário Professor Edgard Santos, Universidade Federal da Bahia, Salvador, Brazil.
Lucy Rodrigues-RibeiroStroke and Cardiomyopathy Clinics, Hospital Universitário Professor Edgard Santos, Universidade Federal da Bahia, Salvador, Brazil.
Victor L P P BotelhoStroke and Cardiomyopathy Clinics, Hospital Universitário Professor Edgard Santos, Universidade Federal da Bahia, Salvador, Brazil.
Maria Carmo P NunesDepartment of Internal Medicine, Faculdade de Medicina, and Telehealth Center and Cardiology Service, Hospital das Clínicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
Antonio Luiz P RibeiroDepartment of Internal Medicine, Faculdade de Medicina, and Telehealth Center and Cardiology Service, Hospital das Clínicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
Lucas C Barbosa E SilvaDepartment of Internal Medicine, Faculdade de Medicina, and Telehealth Center and Cardiology Service, Hospital das Clínicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
Roque ArasStroke and Cardiomyopathy Clinics, Hospital Universitário Professor Edgard Santos, Universidade Federal da Bahia, Salvador, Brazil.
Karen L FurieNeurology Service, Brown University, Providence, Rhode Island, United States of America.
Jamary Oliveira FilhoStroke and Cardiomyopathy Clinics, Hospital Universitário Professor Edgard Santos, Universidade Federal da Bahia, Salvador, Brazil.ORCID 0000-0003-1915-0423

Funding

CHADSS: Chagas Disease Scan StudyR01NS064905 · NINDS · FEDERAL UNIVERSITY OF BAHIA · PI FURIE, KAREN L, OLIVEIRA-FILHO, JAMARY · 2011 to 2015
$1.3M
NINDS NIH HHS R01 NS064905
6 · The paper itself

Abstract

introductionChagas Disease (CD) is frequently associated with heart failure (HF). Cognitive impairment is reported, but whether it results from CD or is a nonspecific symptom of HF is unknown. We aimed to compare cognitive function of HF patients with or without CD.

methodsMulticenter cross-sectional study of HF patients. Investigators blinded to the etiology of HF evaluated global cognition and domains of memory, executive and visuospatial function. Logistic regression tested the association between CD and cognitive impairment (Z-score < -1.5) in each domain adjusted for age, sex, educational level and left ventricular ejection fraction.

resultsWe recruited 518 patients, 250 (48.3%) with CD. Cognitive impairment was more common in CD vs. non-CD patients (27.1% vs 13.1%, p < 0.001), mostly in memory (10.4% vs 5.0%, p = 0.022) and visuospatial function (45.2% vs 29.6%, p < 0.001). In the multivariable analysis, CD remained associated with global cognitive impairment (odds ratio 1.90; 95% CI 1.13-3.21, p = 0.016) and visuospatial function impairment (OR 1.56; 95% CI 1.02-2.39, p = 0.039). DISCUSSION: Chagas disease is associated with cognitive impairment independently of heart failure severity, suggesting other competing mechanisms.

Indexed as

Chagas DiseaseCognitive DysfunctionHeart FailureAdultAgedBrazilCross-Sectional StudiesFemaleHumansMaleMiddle Aged

Identifiers

PMID40440576
PMCPMC12122022

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.